Study of the Use of the Drug Ingaron in Patients With COVID-19

Clinical trial NCT05386459 · COMPLETED

Trial details

NCT number: NCT05386459
Sponsor: SPP Pharmaclon Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Respiratory Infection Viral Pneumonia

Start date: 2020-04-21
Primary completion: 2020-06-17
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.